TABLE 2.

Correlation between monocyte and clinicopathological factors (continuous variables)

		Median (Range)			Comparison at Monocyte Counts
	No.	Initial Diagnosis	Recurrence	P	Median (Range)	r	P
Neut, × 109/L	124	6.0 (0.7–17.9)	4.4 (0.3–21.9)	<0.01	4.4 (0.3–21.9)	0.57	<0.01
Lymph, × 109/L	124	1.8 (0.6–5.5)	1.3 (0.2–3.8)	<0.01	1.3 (0.2–3.8)	0.24	<0.01
N-L ratio	124	3.3 (0.3–21)	3.45 (0.4–38.4)	0.06	3.45 (0.4–38.4)	0.25	<0.01
Mono, × 109/L	124	0.6 (0.1–1.6)	0.5 (0–2.1)	0.68	0.5 (0–2.1)
L-M ratio	124	3.2 (0.0–33.0)	2.7 (0.0–8.0)	<0.01	2.7 (0.0–8.0)
Eos, × 109/L	124	0.1 (0–1.0)	0.1 (0–0.7)	0.02	0.1 (0–0.7)	0.07	0.43
Baso, × 109/L	124	0 (0–0.2)	0 (0–0.2)	<0.01	0 (0–0.2)	0.25	<0.01
Hb, g/dL	133	11.7 (5.3–15.7)	11.8 (6.8–15.7)	0.32	11.8 (6.8–15.7)	−0.15	0.10
Plt, × 109/L	133	316 (65–930)	274 (87–1030)	<0.01	274 (87–1030)	0.43	<0.01
BUN, mg/dL	133	13.0 (4–57)	14.0 (4–110)	<0.01	14.0 (4–110)	0.14	0.13
Cr, mg/dL	133	0.69 (0.2–3.7)	0.66 (0.1–5.4)	0.07	0.66 (0.1–5.4)	0.12	0.20
Alb, mg/L	130	4.0 (2.0–5.9)	4.0 (1.5–8.3)	0.42	4.0 (1.5–8.3)	−0.22	0.02

Number listed is the value at the time of diagnosis or recurrence; mean (±SD) or median (range). Paired t test was used for P values. All factors except eosinophil counts have significant correlations (P < 0.05). Spearman coefficient was also used for P values. Significant P values with r ≥ 0.20 or r ≤ −0.20 are in bold.

Alb, albumin; Baso, basophil; Cr, creatinine; Eos, eosinophil; L-M ratio, lymphocyte-monocyte ratio; Lymph, lymphocyte; Mono, monocyte; Neut, neutrophil; N-L ratio, neutrophil-lymphocyte ratio; Plt, platelet.